Karol Sikora, A. G. Dalgleish (St George's Hospital Medical School, University of London), M. J. Browning (University of
This volume reviews advances in the field of human tumor immunology, particularly in relation to the potential for immune intervention in preventing or treating tumors. The editors and contributors, all leading workers in the field, survey advances in the understanding of the relationship between the cancer cell and the immune response. Chapters review in depth the function of immune surveillance and mechanisms of tumor immunity, the role of T lymphocytes and oncogenes in the immune response to cancer, and the potential for immunotherapy of cancer. New areas of tumor immunology are presented,...
This volume reviews advances in the field of human tumor immunology, particularly in relation to the potential for immune intervention in preventing o...
Herbert M. Pinedo (Vrije Universiteit, Amsterdam), Giuseppe Giaccone (Vrije Universiteit, Amsterdam), Karol Sikora
The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cancer suffer from tumors that are intrinsically resistant to chemotherapy, and most of the remaining half develop drug resistance during the course of their treatment. This book reviews the mechanisms and clinical implications of drug resistance in cancer with unrivaled authority. The authors, who are among the leading clinicians and investigators in the field, cover topics of current clinical concern, including multiple drug resistance and...
The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients w...